Advances in large-molecule biologic treatments—and the emerging shift of care from hospitals and clinics to the home—are two of the factors influencing the ever-evolving healthcare market. To address these issues, BD Medical, a segment of Becton, Dickinson and Co. is developing the BD™ Microinfusor patch injector.
Not yet in use commercially, the BD Microinfusor patch injector offers patients an advanced drug delivery system that allows them to self-administer a biologic therapy as opposed to traveling to and from an acute-care facility such as a hospital, clinic, or doctor’s office for an injection. BD says that for patients with dexterity issues, particularly the elderly, the BD Microinfusor patch injector offers an easier delivery method than autoinjectors or pens.
